Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies
Open accessThe DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is the second most deadly cancer. Global incidence and mortality are likely to be increased in the coming decades. Although the deaths associated with CRC are very high in high-income countries, the incidence and fatalities related to CRC are growing in developing countries too. CRC detected early is entirely curable by surgery and subsequent medications. However, the recurrence rate is high, and cancer drug resistance increases the treatment failure rate. Access to early diagnosis and treatment of CRC for survival is somewhat possible in developed countries. However, these facilities are rarely available in developing countries. Highlighting the current status of CRC, its development, risk factors, and management is crucial in creating public awareness. Therefore, in this review, we have comprehensively discussed the current global epidemiology, drug resistance, challenges, risk factors, and preventive and treatment strategies of CRC. Additionally, there is a brief discussion on the CRC development pathways and recommendations for preventing and treating CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 CRC new cases and deaths in 2020. (a) shows new cases, both sexes and all ages, and (b) shows deaths of both sexes for all age groups. The value shown in % is calculated against the total number of all cancers. The data source is GLOBOCAN [25], taken with permission.](https://figures.cochat.ai/paper-figures/4cc23fff5e894c79bc57ced9f1c8c3e5/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-2.jpg)
![Figure 3 Map showing the global distribution of estimated age-standardized incidence rates (top) and mortality rate (bottom) of CRC in 2020 for both sexes and all ages. (Reproduced from GLOBOCAN [25] with permission).](https://figures.cochat.ai/paper-figures/213c6256c3e144b688935fad2866581f/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-3.jpg)
![Figure 4 World CRC incidence and mortality rates in 2020 (according to income level for all age groups). The data were extracted from GLOBOCAN [25] with permission.](https://figures.cochat.ai/paper-figures/4c8c4ff60d974d3e824dee668004b248/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-4.jpg)
![Figure 5 World new cases and deaths of colon cancer, rectum cancer, and anus cancer in 2020. (a) New cases and (b) deaths of colon cancer, rectum cancer, and anus cancer. The value is shown in % on top of each column and is calculated against the CRC number in 2020 for both sexes and all ages. Data extracted from GLOBOCAN [25] with permission.](https://figures.cochat.ai/paper-figures/d784f84421274ecdb2a36edfe7578100/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite advancements in these therapeutic modalities, resistance remains a significant challenge, often leading to treatment failure, poor progression-free survival, and cancer recurrence.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While overall survival rates for individuals with advanced CRC has increased in recent decades, drug resistance has been reported to develop in nearly all CRC patients [5].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Modifiable factors are associated with the characteristics of a person's lifestyle (obesity, tobacco smoking, alcohol consumption, unhealthy diet)[5-10].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“The development of CRC is associated with the action of non-modifiable and modifiable risk factors.”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 5×
“In 2020, CRC was the most diagnosed cancer (out of 36 cancers) among men in 18 of the 186 countries worldwide and women in 6 of the 185 countries [24].”
BackgroundInfluentialBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“2, which is almost equal to the incidence of 2018 [24,26].”
BackgroundCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · cited 1×
“mechanisms herbs and spices exert are the BCL-2, K-ras, and MMP pathways, caspase activation, the extrinsic apoptotic pathway, and the modulation of ER-stress-induced apoptosis chemopreventive effects [162,163].”
BackgroundA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035 · cited 1×
“Currently, there are clinical studies ongoing on some MAbs for CRC, such as adecatumumab against epithelial cell adhesion molecule (EpCAM), labetuzumab against carcinoembryonic antigen (CEA), and pemtumomab against Mucins [133].”
BackgroundPrevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661 · cited 5×
“There are benign precursor lesions accessible and removed in all pathways, albeit more noticeable in the adenoma–carcinoma and serrated pathways [13].”
BackgroundMethodInfluentialImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345 · cited 1×
“For CRC, a phase II clinical study of the single medication Nivolumab and a mix of dual therapies such as Nivolumab + Ipilimumab is now underway [134].”
BackgroundEdwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Douillard, J.-Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4860 · Cited by 1,809
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687 · cited 4×
“Because of the increasing effectiveness of treatments such as the anti-EGFR (epidermal growth factor receptor) agent cetuximab and the anti-angiogenesis agent bevacizumab are innovative medications that inhibit numerous immunological pathways checkpoints are being developed at an unprecedented rate [106].”
BackgroundInfluentialColorectal cancer screening: Clinical guidelines and rationale
Winawer, S., Fletcher, R., Miller, L., Godlee, F., Stolar, M., Mulrow, C., Woolf, S., Glick, S., Ganiats, T., Bond, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.agast970594 · Cited by 1,612 · cited 1×
“Although the time taken for an early adenoma to progress to an established CRC is yet unknown, the current evidence suggests it to be no less than ten years [9], offering abundant opportunity for detection via screening followed by treatment.”
BackgroundObesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567 · cited 1×
“More significant insulin signaling leads to increased metabolic activity within the cell, which leads to more oxidative stress and DNA damage [46,47].”
BackgroundAlcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342 · cited 1×
“CRC is possible to be prevented by reducing cigarette smoking [71], excessive alcohol consumption [72], overweight or obesity [73], and the consumption of large amounts of red and processed meat [74].”
BackgroundGut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331 · cited 2×
“Again, intestinal microbiota balance depends on the dietary habits and alterations of balanced intestinal microbiota involved with CRC development and progression [68,69].”
BackgroundTowards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067 · cited 2×
“Vaccines also contain components designed to activate DCs that have been pulsated with antigens and direct them to a local lymph node, for example, the DC vaccination and OncoVAX [135].”
Background[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,036
Natural history of untreated colonic polyps
Stryker, S. J., Wolff, B. G., Culp, C. E., Libbe, S. D., Ilstrup, D. M., & MacCarty, R. L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90563-4 · Cited by 939 · cited 1×
“On average, it takes nine years to form metastasis [21].”
BackgroundGene therapy clinical trials worldwide to 2017: An update
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3015 · Cited by 903 · cited 1×
“As of November 2017, nearly 2600 clinical studies had been undertaken in 38 countries, of which more than half included only phase I trials [119].”
BackgroundPhysical activity and survival after colorectal cancer diagnosis
Meyerhardt, J. A., Giovannucci, E. L., Holmes, M. D., Chan, A. T., Chan, J. A., Colditz, G. A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0855 · Cited by 857
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831 · cited 1×
“Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
BackgroundMonoclonal Antibodies in Cancer Therapy
Zahavi, D., & Weiner, L. (2020) · Antibodies · doi:10.3390/antib9030034 · Cited by 831
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817 · cited 1×
“Again, intestinal microbiota balance depends on the dietary habits and alterations of balanced intestinal microbiota involved with CRC development and progression [68,69].”
BackgroundMeta-analyses of colorectal cancer risk factors
Johnson, C. M., Wei, C., Ensor, J. E., Smolenski, D. J., Amos, C. I., Levin, B., & Berry, D. A. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0201-5 · Cited by 779 · cited 5×
“96) for 10 years of HT use compared to no HT use [44].”
BackgroundInfluentialSmoking and Colorectal Cancer: A Meta-analysis
Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., & Maisonneuve, P. (2008) · JAMA · doi:10.1001/jama.2008.839 · Cited by 778
The colorectal adenoma–carcinoma sequence
Leslie, A., Carey, F. A., Pratt, N. R., & Steele, R. J. C. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02120.x · Cited by 734 · cited 1×
“The mutated genes produce the mutated protein that cannot respond typically, and damaged DNA continues the proliferation and accumulates further genetic mutations leading to a malignant phenotype (Leslie et al., 2002).”
BackgroundFedirko, V., Tramacere, I., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Negri, E., Straif, K., Romieu, I., La Vecchia, C., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq653 · Cited by 682 · cited 1×
“An individual with moderate and heavy (≥4 drinks/day) alcohol consumption has a 21 and 52% risk of CRC, respectively [54].”
BackgroundGenetic alterations in colorectal cancer.
Armaghany, T., Wilson, J. D., Chu, Q., & Mills, G. M. (2012) · Europe PMC (PubMed Central) · Cited by 673
Physical activity and colon cancer prevention: a meta-analysis
Wolin, K. Y., Yan, Y., Colditz, G. A., & Lee, I.-M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604917 · Cited by 649 · cited 1×
“A meta-analysis of 52 studies found that physical exercise frequency and intensity are inversely related to CRC risk [53].”
BackgroundColorectal cancer population screening programs worldwide in 2016: An update
Navarro, M., Nicolas, A., Ferrandez, A., & Lanas, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3632 · Cited by 611 · cited 1×
“Therefore, most European countries, Canada, specific regions in North and South America, Asia, and Oceania have initiated population-based screening programs [6].”
BackgroundDallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572 · cited 1×
“Although the response rate to modern systemic chemotherapies can reach as high as 50%, drug resistance is reported to develop in nearly all patients with CRC, limiting the therapeutic efficacy of anticancer drugs and ultimately leading to chemotherapy failure [33,34].”
BackgroundTriantafillidis, J. K., Nasioulas, G., & Kosmidis, P. (2009) · PubMed · Cited by 558
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., & Engleman, E. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141226398 · Cited by 541 · cited 1×
“An amalgamation of targeted immunotherapy and surgery significantly increases patient survival rates [137,138].”
BackgroundPapamichael, D., Audisio, R. A., Glimelius, B., de Gramont, A., Glynne-Jones, R., Haller, D., Köhne, C.-H., Rostoft, S., Lemmens, V., Mitry, E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu253 · Cited by 471
Colorectal cancer screening: Clinical guidelines and rationale
Ransohoff, D., Lang, C., & Young, G. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.agast971131423 · Cited by 469
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
Coyle, C., Cafferty, F. H., Vale, C., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 452 · cited 1×
“RCTs are also required to evaluate further initial indications that metformin can enhance survival rates among patients with CRC [97].”
BackgroundVieira, A. R., Abar, L., Chan, D. S. M., Vingeliene, S., Polemiti, E., Stevens, C., Greenwood, D., & Norat, T. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx171 · Cited by 452 · cited 2×
“CRC is possible to be prevented by reducing cigarette smoking [71], excessive alcohol consumption [72], overweight or obesity [73], and the consumption of large amounts of red and processed meat [74].”
BackgroundMolecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Malki, A., ElRuz, R. A., Gupta, I., Allouch, A., Vranic, S., & Al Moustafa, A.-E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010130 · Cited by 398
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396 · cited 1×
“TNF and interleukin-6 are critical factors in CRC as they stimulate the major oncogenic factors, nuclear factor-B, and inducer of transcription 3 (STAT3) in intestinal cells, promoting proliferation and resistance against apoptosis [141].”
BackgroundMechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381 · cited 1×
“Although the response rate to modern systemic chemotherapies can reach as high as 50%, drug resistance is reported to develop in nearly all patients with CRC, limiting the therapeutic efficacy of anticancer drugs and ultimately leading to chemotherapy failure [33,34].”
BackgroundTesta, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371 · cited 2×
“More significant insulin signaling leads to increased metabolic activity within the cell, which leads to more oxidative stress and DNA damage [46,47].”
BackgroundPopulation-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
Cao, Y., Nishihara, R., Wu, K., Wang, M., Ogino, S., Willett, W. C., Spiegelman, D., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.6396 · Cited by 369 · cited 1×
“Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
BackgroundHossain, M. S., Urbi, Z., Sule, A., & Rahman, K. M. H. (2014) · The Scientific World Journal · doi:10.1155/2014/274905 · Cited by 341 · cited 1×
“An estimation reported that approximately 75–80% of the world’s population uses traditional medical systems as their first therapy option due to lack of access to treatment facilities as well as worries about synthetic medicine safety and efficacy [144,145].”
BackgroundSelf-citationBoyle, T., Keegel, T., Bull, F., Heyworth, J., & Fritschi, L. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs354 · Cited by 336 · cited 1×
“Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
BackgroundRisk Factors Associated With Early-Onset Colorectal Cancer
Gausman, V., Dornblaser, D., Anand, S., Hayes, R. B., O'Connell, K., Du, M., & Liang, P. S. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.10.009 · Cited by 298 · cited 1×
“Cigarette smoking is a modifiable risk factor for developing CRC, and the risk of CRC increases with the increasing number of cigarettes consumed [35,38,44].”
Background[Genetic alterations in colorectal cancer].
Laurent‐Puig, P. (1994) · PubMed · Cited by 293
Diet and colorectal cancer in UK Biobank: a prospective study
Bradbury, K. E., Murphy, N., & Key, T. J. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyz064 · Cited by 280 · cited 3×
“On the other hand, white meat such as fish and poultry is safe and not associated with CRC risk [60,61].”
BackgroundInfluentialThe molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
Nguyen, H., & Duong, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8679 · Cited by 244
Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R. B., Moh Qrimida, A., Allzrag, A. M. M., Ming, L. C., Pagano, E., & Capasso, R. (2021) · Life · doi:10.3390/life11040348 · Cited by 242 · cited 1×
“On the other hand, natural products have grown in importance as sources of polypharmacological treatments for infectious diseases, malignancies, and neurological disorders [146,147].”
BackgroundSelf-citationNatural products for treating colorectal cancer: A mechanistic review
Huang, X.-M., Yang, Z.-J., Xie, Q., Zhang, Z.-K., Zhang, H., & Ma, J.-Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109142 · Cited by 225 · cited 2×
“Ongoing research and development into natural products result in nearly 50% of currently available cancer treatments being derived directly or indirectly from natural ingredients [151,152].”
BackgroundRole of Physical Activity and Diet After Colorectal Cancer Diagnosis
Van Blarigan, E. L., & Meyerhardt, J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7799 · Cited by 222
Colorectal Cancer and Alcohol Consumption—Populations to Molecules
Rossi, M., Jahanzaib Anwar, M., Usman, A., Keshavarzian, A., & Bishehsari, F. (2018) · Cancers · doi:10.3390/cancers10020038 · Cited by 207 · cited 1×
“Furthermore, alcoholics are susceptible to a poor diet deficient in folate and fiber, as well as circadian disruption, which may exacerbate alcohol-induced colon cancer [57].”
BackgroundThe evolution of colorectal carcinoma
Morson, B. C. (1984) · Clinical Radiology · doi:10.1016/s0009-9260(84)80033-1 · Cited by 193 · cited 1×
“Screening is particularly appropriate in CRC, as it is not only a common disorder but one thought to be characterized by a gradual development of the adenoma–carcinoma sequence [8].”
BackgroundRed meat and colorectal cancer
Aykan, N. F. (2015) · Oncology Reviews · doi:10.4081/oncol.2015.288 · Cited by 188
O'Keefe, S. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30257-2 · Cited by 186
NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer.
Messersmith, W. A. (2019) · PubMed · doi:10.6004/jnccn.2019.5014 · Cited by 182 · cited 2×
“Notably, chemotherapy or radiotherapy may be used before or after surgery to help shrink or stabilize the tumor [105].”
BackgroundSmoking and survival of colorectal cancer patients: systematic review and meta-analysis
Walter, V., Jansen, L., Hoffmeister, M., & Brenner, H. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu040 · Cited by 171
Gene-Directed Enzyme Prodrug Therapy
Zhang, J., Kale, V. M., & Chen, M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9675-7 · Cited by 163
Development of a Risk Score for Colorectal Cancer in Men
Driver, J. A., Gaziano, J. M., Gelber, R. P., Lee, I.-M. M., Buring, J. E., & Kurth, T. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.055 · Cited by 159 · cited 3×
“Cigarette smoking is a modifiable risk factor for developing CRC, and the risk of CRC increases with the increasing number of cigarettes consumed [35,38,44].”
BackgroundPickhardt, P. J., Kim, D. H., Pooler, B. D., Hinshaw, J. L., Barlow, D. S., Jensen, D., Reichelderfer, M., & Cash, B. D. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70216-x · Cited by 156 · cited 1×
“Adenocarcinomas account for roughly 96% of all CRC [20].”
Li, P., Wu, H., Zhang, H., Shi, Y., Xu, J., Ye, Y., Xia, D., Yang, J. J., Cai, J., & Wu, Y. (2014) · Gut · doi:10.1136/gutjnl-2014-308260 · Cited by 154 · cited 1×
“Multiple observational studies have concluded that the consumption of low-dose aspirin, which is already associated with reduced CRC risk, also promotes survival rates after CRC diagnosis [94], possibly due to COX inhibition [95];”
BackgroundPlasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer
Zgaga, L., Theodoratou, E., Farrington, S. M., Din, F. V. N., Ooi, L. Y., Glodzik, D., Johnston, S., Tenesa, A., Campbell, H., & Dunlop, M. G. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5947 · Cited by 148 · cited 1×
“Epidemiological research has also indicated an association between vitamin D deficiency, commonly seen in patients with CRC [62], and significantly lower chances of survival [99,100].”
BackgroundFreisling, H., Arnold, M., Soerjomataram, I., O'Doherty, M. G., Ordóñez-Mena, J. M., Bamia, C., Kampman, E., Leitzmann, M., Romieu, I., Kee, F., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.106 · Cited by 145 · cited 1×
“CRC is possible to be prevented by reducing cigarette smoking [71], excessive alcohol consumption [72], overweight or obesity [73], and the consumption of large amounts of red and processed meat [74].”
BackgroundEfficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery
Suktham, K., Koobkokkruad, T., Wutikhun, T., & Surassmo, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.015 · Cited by 141
Irby, K. B., Anderson, W. F., Henson, D. E., & Devesa, S. S. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0879 · Cited by 141 · cited 1×
“Although both genders are likely to develop CRC, males are more likely than females to develop CRC [37].”
BackgroundCommunity Factors in the Development of Antibiotic Resistance
Larson, E. (2006) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144020 · Cited by 139 · cited 1×
“BMI was significantly correlated with rectal cancer in men but not in women [52].”
BackgroundInhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide
Shi, M., Lin, H., Lee, Y.-C., Chao, J., Lin, R.-A., & Chen, J. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.06.006 · Cited by 138
Li, W., Liu, D., Zhang, H., Correia, A., Mäkilä, E. M., Salonen, J., Hirvonen, J. J., & Santos, H. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.042 · Cited by 138
Ciccolallo, L., Capocaccia, R., Coleman, M. P., Berrino, F., Coebergh, J. W. W., Damhuis, R. A. M., Faivre, J., Martinez-Garcia, C., Møller, H., de Leòn, M. P., et al. (2005) · Gut · doi:10.1136/gut.2004.044214 · Cited by 136 · cited 1×
“Furthermore, CRC can be prevented by removing colorectal adenomas [10], and the earlier the CRC is detected, the less likely the patient will die [11].”
BackgroundTobacco Smoking and Postoperative Outcomes After Colorectal Surgery
Sharma, A., Deeb, A.-P., Iannuzzi, J. C., Rickles, A. S., Monson, J. R. T., & Fleming, F. J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182708cc5 · Cited by 135 · cited 1×
“Although the exact mechanism associating lower survival rates with these specific risk factors has not been identified, higher rates of surgical complications, suboptimal responses to chemotherapy and radiotherapy, and nicotine-induced suppression of cancer cell apoptosis and enhancement of cell migration are all thou…”
BackgroundBrenner, H., Altenhofen, L., Stock, C., & Hoffmeister, M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0162 · Cited by 131 · cited 1×
“Unlike other cancers, CRC is generally characterized by slow development over several years to decades after normal colorectal epithelium is transformed into an adenoma [79].”
BackgroundPedersen, A., Johansen, C., & Grønbæk, M. (2003) · Gut · doi:10.1136/gut.52.6.861 · Cited by 128 · cited 1×
“After more than 14 years of follow-up, a Danish population-based cohort study revealed that drinkers of more than 40 drinks a week had a relative risk of rectal cancer of more than twice compared to non-drinkers [56].”
BackgroundVaughan-Shaw, P. G., Buijs, L. F., Blackmur, J. P., Τheodoratou, E., Zgaga, L., Din, F. V. N., Farrington, S. M., & Dunlop, M. G. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01060-8 · Cited by 124 · cited 1×
“A systematic review and meta-analysis of randomized controlled trials reported that vitamin D supplementation has a clinically significant effect on CRC survival outcomes [101,102].”
BackgroundRole of phytochemicals in colorectal cancer prevention
Li, Y.-H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i31.9262 · Cited by 111
Sharma, A. K., Kim, E. J., Shi, H., Lee, J. Y., Chung, B. G., & Kim, J. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.019 · Cited by 110
Lesterhuis, W. J., de Vries, I. J. M., Schuurhuis, D. H., Boullart, A. C. I., Jacobs, J. F. M., de Boer, A. J., Scharenborg, N. M., Brouwer, H., van de Rakt, M. W. M. M., Figdor, C. G., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl072 · Cited by 108 · cited 1×
“Most CRC people who underwent DC vaccination exhibited CEA-specific T-cell immunological responses in advanced CRC patients [136].”
BackgroundSong, Z., Lin, Y., Zhang, X., Feng, C., Lu, Y., Gao, Y., & Dong, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125573 · Cited by 108
Safiejko, K., Tarkowski, R., Koselak, M., Juchimiuk, M., Tarasik, A., Pruc, M., Smereka, J., & Szarpak, Ł. (2021) · Cancers · doi:10.3390/cancers14010180 · Cited by 106 · cited 1×
“Surgery is a standard treatment procedure for CRC, particularly for stage 0 to stage II [30,31].”
BackgroundGreen, J., Czanner, G., REEVES, G. K., Watson, J. R., Wise, L., Roddam, A., & Beral, V. (2011) · International Journal of Cancer · doi:10.1002/ijc.26236 · Cited by 105 · cited 1×
“Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
BackgroundSteele, S. R., Park, G. E., Johnson, E. K., Martin, M. J., Stojadinovic, A., Maykel, J. A., & Causey, M. W. (2014) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e3182a586e7 · Cited by 104 · cited 2×
“[36] revealed that of the 7948 CRC patients, 77% were between 50 and 79 years of age.”
BackgroundWu, D., Wu, P., Wu, X., Ye, J., Wang, Z., Zhao, S., Ni, C., Hu, G., Xu, J., Han, Y., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.992749 · Cited by 103 · cited 1×
“In a human colon cancer xenografted mice model, ex vivo-grown human Vδ1 γδ T cells showed extraordinary therapeutic potential [139].”
BackgroundChitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer
Sadreddini, S., Safaralizadeh, R., Baradaran, B., Aghebati-Maleki, L., Hosseinpour-Feizi, M. A., Shanehbandi, D., Jadidi-Niaragh, F., Sadreddini, S., Kafil, H. S., Younesi, V., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2016.11.013 · Cited by 101
Epidemiology and biology of physical activity and cancer recurrence
Friedenreich, C. M., Shaw, E., Neilson, H. K., & Brenner, D. R. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1558-9 · Cited by 100 · cited 1×
“Among the mechanisms investigated and proposed to explain this link are the reduced whole-body and visceral fatness, metabolic dysregulation, chronic inflammation, oxidative stress, and the enhanced immune function associated with participation in physical activity [90].”
BackgroundEffect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
Fuggetta, M. P., Lanzilli, G., Tricarico, M., Cottarelli, A., Falchetti, R., Ravagnan, G., & Bonmassar, E. (2006) · PubMed · Cited by 99
Aspirin, cyclooxygenase inhibition and colorectal cancer
Sostres, C., Gargallo-Puyuelo, C. J., & Lanas, A. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i1.40 · Cited by 98 · cited 1×
“Multiple observational studies have concluded that the consumption of low-dose aspirin, which is already associated with reduced CRC risk, also promotes survival rates after CRC diagnosis [94], possibly due to COX inhibition [95];”
BackgroundHazama, S., Nakamura, Y., Takenouchi, H., Suzuki, N., Tsunedomi, R., Inoue, Y., Tokuhisa, Y., Iizuka, N., Yoshino, S., Takeda, K., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-63 · Cited by 93
Weberpals, J. G., Jansen, L., Carr, P. R., Hoffmeister, M., & Brenner, H. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.04.004 · Cited by 93 · cited 1×
“However, it is thought that significant flaws, such as immortal time bias, in certain important pharmacoepidemiological studies [98] led to the frequent administration of certain drugs, including beta-blockers, to treat comorbidities in patients with CRC, which have since been demonstrated to have no value in this pop…”
BackgroundDietary calcium, vitamin D, and the risk of colorectal cancer
Ishihara, J., Inoue, M., Iwasaki, M., Sasazuki, S., & Tsugane, S. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26195 · Cited by 89 · cited 1×
“Therefore, supplemental calcium and vitamin D indicate a potential decreased risk of CRC [63,64].”
BackgroundOrdóñez-Mena, J. M., Walter, V., Schöttker, B., Jenab, M., O’Doherty, M. G., Kee, F., Bueno-de-Mesquita, B. H., Peeters, P. H. M., Stricker, B. H. C., Ruiter, R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx761 · Cited by 89
Racial variation in colorectal polyp and tumor location.
Thornton, J. G., Morris, A. M., Thornton, J. D., Flowers, C. R., & McCashland, T. M. (2007) · PubMed Central · Cited by 88
Hazama, S., Nakamura, Y., Tanaka, H., Hirakawa, K., Tahara, K., Shimizu, R., Ozasa, H., Etoh, R., Sugiura, F., Okuno, K., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-108 · Cited by 86
Hosseinifar, T., Sheybani, S., Abdouss, M., Hassani Najafabadi, S. A., & Shafiee Ardestani, M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36242 · Cited by 81
Site-Specific Risk Factors for Colorectal Cancer in a Korean Population
Shin, A., Joo, J., Bak, J., Yang, H.-R., Kim, J., Park, S., & Nam, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023196 · Cited by 80 · cited 2×
“A Korean cohort study involving more than 3000 men and more than 1000 women showed that moderate and heavy alcohol consumption was associated with an increased risk for distal colon cancer in men and a higher risk for rectal cancer in women [48].”
BackgroundWalter, V., Jansen, L., Ulrich, A. B., Roth, W., Bläker, H., Chang-Claude, J. C., Hoffmeister, M., & Brenner, H. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.127092 · Cited by 77
Smit, W. L., Spaan, C. N., Johannes de Boer, R., Ramesh, P., Martins Garcia, T., Meijer, B. J., Vermeulen, J. L. M., Lezzerini, M., MacInnes, A. W., Koster, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912772117 · Cited by 77
Garland, C. F., & Gorham, E. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.003 · Cited by 76 · cited 2×
“Epidemiological research has also indicated an association between vitamin D deficiency, commonly seen in patients with CRC [62], and significantly lower chances of survival [99,100].”
BackgroundGuercio, B. J., Zhang, S., Ou, F., Venook, A. P., Niedzwiecki, D., Lenz, H., Innocenti, F., O’Neil, B. H., Shaw, J. E., Polite, B. N., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01019 · Cited by 73 · cited 1×
“However, a prospective cohort study that included more than 1200 patients found no statistically significant association of physical activity with overall survival among patients with metastatic CRC [93].”
BackgroundColorectal Cancer Incidence Trends by Age, Stage, and Racial/Ethnic Group in California, 1990–2014
Ellis, L., Abrahão, R., McKinley, M. A., Yang, J., Somsouk, M., Marchand, L. L., Cheng, I. C., Gomez, S. L., & Shariff‐Marco, S. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0030 · Cited by 72 · cited 1×
“The incidence of late-stage colorectal cancer was 30 to 60% lower in several Asian American groups (Korean and South Asian men and women and Chinese women) [40,41].”
BackgroundAnticancer Efficacy of Self-Nanoemulsifying Drug Delivery System of Sunitinib Malate
Alshahrani, S. M., Alshetaili, A., Alalaiwe, A. S., Alsulays, B. B., Anwer, M. K., Al‐Shdefat, R., Imam, F., & Shakeel, F. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0826-x · Cited by 71
Orsini, G., Legitimo, A., Failli, A., Ferrari, P., Nicolini, A., Spisni, R., Miccoli, P., & Consolini, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122022 · Cited by 70 · cited 1×
“An amalgamation of targeted immunotherapy and surgery significantly increases patient survival rates [137,138].”
BackgroundHereditary and Common Familial Colorectal Cancer: Evidence for Colorectal Screening
Samadder, N. J., Jasperson, K. W., & Burt, R. W. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3465-z · Cited by 70 · cited 1×
“The risk of developing colorectal cancer for individuals with untreated FAP is almost 100% [49,50].”
BackgroundMechanisms for nicotine in the development and progression of gastrointestinal cancers.
Jensen, K. J., Afroze, S. H., Munshi, K., Guerrier, M., & Glaser, S. S. (2012) · PubMed · doi:10.3978/j.issn.2224-4778.2011.12.01 · Cited by 69 · cited 1×
“Nicotine also stimulates angiogenesis and neovascularization in colon cancer through increases in VEGF, 5-LOX, COX-2, and matrix metalloproteinase-2/9 (MMP-2/9) [59].”
BackgroundCheewatanakornkool, K., Niratisai, S., Manchun, S., Dass, C. R., & Sriamornsak, P. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.07.005 · Cited by 69
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives
Nappi, A., Berretta, M., Romano, C., Tafuto, S., Cassata, A., Casaretti, R., Silvestro, L., Divitiis, C. D., Alessandrini, L., Fiorica, F., et al. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009617666170209095143 · Cited by 68
Smoking and survival of colorectal cancer patients: Population-based study from Germany
Walter, V., Jansen, L., Hoffmeister, M., Ulrich, A. B., Chang-Claude, J. C., & Brenner, H. (2015) · International Journal of Cancer · doi:10.1002/ijc.29511 · Cited by 67
Risk factors for colorectal cancer significantly vary by anatomic site
Demb, J., Earles, A., Martínez, M. E., Bustamante, R., Bryant, A. K., Murphy, J. D., Liu, L., & Gupta, S. N. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000313 · Cited by 67
Otto, S. J., Korfage, I. J., Polinder, S., van der Heide, A., de Vries, E., Rietjens, J. A. C., & Soerjomataram, I. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2480-0 · Cited by 66
Maalmi, H., Walter, V., Jansen, L., Chang-Claude, J. C., Owen, R. W., Ulrich, A. B., Schöttker, B., Hoffmeister, M., & Brenner, H. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0298-z · Cited by 66
Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex
Gram, I. T., Park, S.-Y., Wilkens, L. R., Haiman, C. A., & Le Marchand, L. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa005 · Cited by 66 · cited 1×
“Female smokers had a greater risk of rectal cancer compared to male smokers [58].”
BackgroundA Review of Current Challenges in Colorectal Cancer Reporting
Dawson, H., Kirsch, R., Messenger, D. E., & Driman, D. K. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0475-ra · Cited by 63 · cited 1×
“In addition, there are issues in examining and reporting these specimens, either because of difficulty in implementing existing criteria or introducing new concepts [32].”
BackgroundFlaxseed Bioactive Compounds and Colorectal Cancer Prevention
DeLuca, J. A. A., Garcia-Vilarato, E., & Allred, C. D. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0704-z · Cited by 62
Primary prevention of colorectal cancer: Myth or reality?
Teixeira, M. C., Braghiroli, M. I., Sabbaga, J., & Hoff, P. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15060 · Cited by 57
Stingl, J., Ettrich, T. J., Muche, R., Wiedom, M., Brockmöller, J., Seeringer, A., & Seufferlein, T. T. W. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-360 · Cited by 57
Physical activity and survival of colorectal cancer patients: Population‐based study from Germany
Walter, V., Jansen, L., Knebel, P., Chang‐Claude, J., Hoffmeister, M., & Brenner, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30619 · Cited by 57
Boughanem, H., Canudas, S., Hernández‐Alonso, P., Becerra‐Tomás, N., Babió, N., Salas‐Salvadó, J., & Macías‐González, M. (2021) · Cancers · doi:10.3390/cancers13112814 · Cited by 54 · cited 1×
“A systematic review and meta-analysis of randomized controlled trials reported that vitamin D supplementation has a clinically significant effect on CRC survival outcomes [101,102].”
BackgroundBrenner, H., Jansen, L., Saum, K.-U., Holleczek, B., & Schöttker, B. (2017) · Journal of Nutrition · doi:10.3945/jn.117.250191 · Cited by 52 · cited 1×
“Further RCTs are required to assess the role of vitamin D supplementation in tertiary prevention [104].”
BackgroundNicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs
Dinicola, S., Morini, V., Coluccia, P., Proietti, S., D’Anselmi, F., Pasqualato, A., Masiello, M. G., Palombo, A., Toma, G. D., Bizzarri, M., et al. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.09.020 · Cited by 50 · cited 1×
“Although the exact mechanism associating lower survival rates with these specific risk factors has not been identified, higher rates of surgical complications, suboptimal responses to chemotherapy and radiotherapy, and nicotine-induced suppression of cancer cell apoptosis and enhancement of cell migration are all thou…”
BackgroundMenopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
Botteri, E., Støer, N. C., Sakshaug, S., Graff‐Iversen, S., Vangen, S., Hofvind, S. S. H., de Lange, T., Bagnardi, V., Ursin, G., & Weiderpass, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017639 · Cited by 48
Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
Downs‐Canner, S., Magge, D. R., Ravindranathan, R., O’Malley, M. E., Francis, L., Liu, Z., Guo, Z. S., Obermajer, N., & Bartlett, D. L. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4778-7 · Cited by 42 · cited 1×
“It can also be used as a combination immunotherapy regimen [140].”
BackgroundDietary Fibre Protective against Colorectal Cancer Patients in Asia: A Meta-Analysis
Masrul, M., & Nindrea, R. D. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.265 · Cited by 42
Inulin based glutathione-responsive delivery system for colon cancer treatment
Wang, D., Sun, F., Lu, C., Chen, P., Wang, Z., Qiu, Y., Mu, H., Miao, Z., & Duan, J. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.071 · Cited by 41
The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence
Frouws, M. A., van Herk‐Sukel, M. P. P., Maas, H. A., van de Velde, C. J. �., Portielje, J. E. A., Liefers, G., & Bastiaannet, E. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.008 · Cited by 40 · cited 1×
“investigations of additional roles of non-COX mechanisms have been initiated to explore and define a potential role for aspirin in tertiary prevention [96].”
BackgroundJi, J., Sundquist, J., & Sundquist, K. (2017) · International Journal of Cancer · doi:10.1002/ijc.31228 · Cited by 39 · cited 1×
“Exogenous postmenopausal hormone replacement therapy is associated with a decreased risk of CRC, cancer-related mortality, and all-cause mortality [65,66].”
BackgroundCronin, K. A., Krebs‐Smith, S. M., Feuer, E. J., Troiano, R. P., & Ballard-Barbash, R. R. (2001) · Cancer Causes & Control · doi:10.1023/a:1011244700531 · Cited by 38
Stage of colon cancer at diagnosis: implications for risk factor associations?
Slattery, M. L., Edwards, S. L., & Samowitz, W. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.3.382 · Cited by 38 · cited 1×
“The stage determines the severity of the disease and the therapy options available [23].”
BackgroundA case–control study of risk factors for colorectal cancer in an African population
Katsidzira, L., Gangaidzo, I. T., Makunike-Mutasa, R., Manyanga, T., Zingoni, Z. M., Thomson, S. R., Matenga, J. A., Rusakaniko, S., & Ramesar, R. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000439 · Cited by 38
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine
Riley, J. M., Cross, A. W., Paulos, C. M., Rubinstein, M. P., Wrangle, J. M., & Camp, E. R. (2018) · Cancer · doi:10.1002/cncr.31214 · Cited by 37
Su, C.-Y., Liu, J., Ho, Y., Huang, Y., Chang, V. H.-S., Liu, D.-Z., Chen, L.-C., Ho, H., & Sheu, M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.11.006 · Cited by 36
Isolation, Characterization and Neuroprotective Activity of Folecitin: An In Vivo Study
Farooq, U., Khan, T., Shah, S. A., Hossain, M. S., Ali, Y., Ullah, R., Raziq, N., Shahid, M. M., & Capasso, R. (2021) · Life · doi:10.3390/life11080825 · Cited by 36 · cited 1×
“On the other hand, natural products have grown in importance as sources of polypharmacological treatments for infectious diseases, malignancies, and neurological disorders [146,147].”
BackgroundSelf-citationColorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study
Vallès, X., Alonso, M. H., López-Caleya, J. F., Díez‐Obrero, V., Dierssen‐Sotos, T., Lope, V., Molina‐Barceló, A., Chirlaque, M. D., Jiménez‐Moleón, J. J., Fernández‐Tardón, G., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.09.030 · Cited by 34 · cited 1×
“Therefore, supplemental calcium and vitamin D indicate a potential decreased risk of CRC [63,64].”
BackgroundHossain, M. S., & Urbi, Z. (2016) · International Journal of Agronomy · doi:10.1155/2016/1617543 · Cited by 32 · cited 1×
“Nature contains plenty of sources for the first line of treatment and prominent compounds to treat many severe diseases [142,143].”
BackgroundSelf-citationThe integration of molecular genetics into cancer management
Weinberg, R. A. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1701::aid-cncr2820701609>3.0.co;2-s · Cited by 31
Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells
Eo, H. J., Park, G. H., & Jeong, J. B. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.154 · Cited by 31
Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer
García‐Etxebarria, K., Clos‐Garcia, M., Telleria, O., Jiménez, B. N., Alonso, C., Iruarrizaga‐Lejarreta, M., Franke, A., Crespo, A., Iglesias, Á., Cubiella, J., et al. (2021) · Cancers · doi:10.3390/cancers13246216 · Cited by 31 · cited 1×
“The metabolome helped identify the important biological activities affected by genetic variation [12].”
BackgroundGe, L., Wang, Y.-F., Tian, J., Mao, L., Zhang, J., Zhang, J.-H., Shen, X.-P., & Yang, K. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12410 · Cited by 30 · cited 1×
“A network meta-analysis demonstrates that Ai-Di, Shen-Qi-Fu-Zheng, and Matrine injections, which the Chinese FDA has approved, improve the overall response rate and quality of life in advanced colorectal cancer patients treated with oxaliplatin, 5-fluorouracil, and leucovorin, as well as reduce peripheral neurotoxicit…”
BackgroundGenetic unraveling of colorectal cancer
Rasool, S., Rasool, V., Naqvi, T., Ganai, B. A., & Shah, B. A. (2014) · Tumor Biology · doi:10.1007/s13277-014-1713-7 · Cited by 28
Lin, T.-C., Chien, W., Hu, J., Tzeng, N., Chung, C., Pu, T., Hsiao, C.-W., & Chen, C.-Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232740 · Cited by 28 · cited 1×
“The longer the period of alcohol consumption, the higher the risk of having CRC [55].”
BackgroundStrategies for Colon Cancer Prevention: Combination of chemopreventive agents
Reddy, B. S. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_10 · Cited by 24 · cited 1×
“However, researchers in many countries seek novel biomarkers, such as blood-based ‘omics signatures’, which could bring critical new advancements to the current range of available noninvasive or minimally invasive CRC screening tests [80].”
BackgroundHunyadi, J., András, C., Szabó, I., Szántó, J., Szluha, K., Sipka, S., Kovacs, P. L., Kiss, A., Szegedi, G., Altorjay, I., et al. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9704-3 · Cited by 23
Multistep carcinogenesis in colorectal cancers.
Takami, K., Yana, I., Kurahashi, H., & Nishisho, I. (1995) · PubMed · Cited by 21
Principles and applications of gene therapy in colon cancer.
Durai, R., Yang, S. Y., Seifalian, A. M., & Winslet, M. C. (2008) · PubMed · Cited by 21
Ng, K., Nimeiri, H. S., McCleary, N. J., Abrams, T. A., Yurgelun, M. B. B., Cleary, J. M., Rubinson, D. A., Schrag, D., Allen, J. N., Zuckerman, D. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3506 · Cited by 21 · cited 1×
“The findings of a recent randomized phase II trial indicated improved progression-free survival among patients with metastatic CRC who took high-dose vitamin D supplements [103].”
BackgroundApplication Potential of Polymeric Nanoconstructs for Colon-Specific Drug Delivery
Jain, S., Tiwari, A., Jain, A., Verma, A., Saraf, S., Panda, P. K., & Gour, G. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-4781-5.ch002 · Cited by 20
Hong, J., & Park, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18062896 · Cited by 19 · cited 1×
“5 MET-hours per week of physical activity [91].”
BackgroundFaecal Diagnostic Biomarkers for Colorectal Cancer
Cruz, A., Carvalho, C. M., Cunha, A. P., Crespo, A., Iglesias, Á., García‐Nimo, L., Freitas, P. P., & Cubiella, J. (2021) · Cancers · doi:10.3390/cancers13215568 · Cited by 18 · cited 1×
“mechanisms herbs and spices exert are the BCL-2, K-ras, and MMP pathways, caspase activation, the extrinsic apoptotic pathway, and the modulation of ER-stress-induced apoptosis chemopreventive effects [162,163].”
BackgroundA secondary Research on Medicinal Plants Mentioned in the Holy Qur’an
Hossain, M. S., Urbi, Z., Evamoni, F. Z., Zohora, F. T., & Rahman, K. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 16
Self-citationUrbi, Z., & Zainuddin, Z. (2015) · Jurnal Teknologi · doi:10.11113/jt.v77.6722 · Cited by 13 · cited 1×
“Nature contains plenty of sources for the first line of treatment and prominent compounds to treat many severe diseases [142,143].”
BackgroundSelf-citationHossain, M. S., Urbi, Z., & Phang, I. C. (2021) · Agronomy Journal · doi:10.1002/agj2.20745 · Cited by 13
Self-citationHossain, M. S. (2016) · Cited by 11
Self-citationRisk Factors for Colorectal Cancer
Y Peterson, C. (2015) · MOJ Surgery · doi:10.15406/mojs.2015.02.00015 · Cited by 6
How and when adjuvant treatment should be intensified in stage III colorectal cancers?
Saleh, K., Khalifé-Saleh, N., Kourié, H. R., & Chahine, G. Y. (2017) · Future Oncology · doi:10.2217/fon-2017-0197 · Cited by 3
Research works printed but not linked: 1
- Urbi, 2014, Grape: A medicinal fruit species in the holy Qur’an and its ethnomedicinal importance, World Appl. Sci. J., 30, 253
Cited by
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Hossain, M. S., Kader, M. A., Goh, K. W., Islam, M., Khan, M. S., Harun-Ar Rashid, M., Ooi, D. J., Melo Coutinho, H. D., Al-Worafi, Y. M., Moshawih, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865801 · Cited by 346
Self-citationHigh-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer
Oliveira, M. F. D., Romero, J. P., Chung, M., Williams, S. R., Gottscho, A. D., Gupta, A., Pilipauskas, S. E., Mohabbat, S., Raman, N., Sukovich, D. J., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02193-3 · Cited by 321
“Additionally, comparing these metrics with other high-resolution methods like Stereo-seq or Seq-scope could enhance the manuscript's appeal and provide a clearer benchmark for readers.”
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., Giuliano, A., Lapadula, S., Lettini, A. R., & Sanseverino, F. (2024) · Nutrients · doi:10.3390/nu16060800 · Cited by 240
“There are several factors responsible for its pathology, including environmental factors, genetic factors such as family history, and chronic inflammation, but also factors that include diet and lifestyle [182,183].”
BackgroundDattilo, M., Patitucci, F., Prete, S., Parisi, O. I., & Puoci, F. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14020055 · Cited by 174
“Its global incidence is becoming constantly higher, and it is estimated to reach more than double by 2035, especially in less developed nations, where early diagnosis and treatment are rarely available [132].”
Background
Metadata
- Authors
- Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., Goh, K. W., & Hadi, M. A.
- Affiliations
- International Islamic University Malaysia (MY)
- Universiti Sains Malaysia (MY)
- Universiti Malaysia Pahang Al-Sultan Abdullah (MY)
- Mahsa University (MY)
- Universiti Brunei Darussalam (BN)
- Mawlana Bhashani Science and Technology University (BD)
- INTI International University (MY)
- Qatar University (QA)
- Corresponding author
- Hossain, Md. Sanower
- Ming, Long Chiau
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-03-29
- Volume
- 14
- Issue
- 7
- Pages
- 1732
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8996939
- OpenAlex
- W4220871154
- Semantic Scholar
- a177fa591329da9c54d205f532c08c603177d297
- Cited by
- 920
- References
- 156
- Citations by year
- 2026: 169 · 2025: 307 · 2024: 267 · 2023: 150 · 2022: 23
- FWCI
- 22.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UMP Institutional Repository (Universiti Malaysia Pahang) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- colorectal cancer, carcinogenesis, global epidemiology, risk factors, cancer prevention, cancer therapy, drug resistance, tumor recurrence, early diagnosis, access to treatment, developing countries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.